These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 174177)

  • 1. [Study of adverse reactions in pulmonary tuberculosis patients treated with rifampicin].
    Anastasatu C; Dinulică E; Algeorge G; Cărpinişan L; Varga E; Rudescu D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):213-9. PubMed ID: 174177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adverse reactions to antitubercular treatment with rifampin (Considerations on 14 cases].
    Didilescu C; Rădulescu G; Filip G; Constantinescu I; Măgălie D; Satcău C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(3):177-80. PubMed ID: 229543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis].
    Fokina LV; Vusygina RN; Antosik OD
    Probl Tuberk; 1976 Feb; (21):34-9. PubMed ID: 1264980
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.
    Aquinas M; Allan WG; Horsfall PA; Jenkins PK; Hung-Yan W; Girling D; Tall R; Fox W
    Br Med J; 1972 Mar; 1(5803):765-71. PubMed ID: 4259217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capreomycin, ethambutol and rifampicin in apparently incurable pulmonary tuberculosis.
    Hellström PE; Repo UK
    Scand J Respir Dis Suppl; 1969; 69():69-74. PubMed ID: 4906377
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects of adverse reactions during treatment with rifampicin].
    Zeană C; Bănică D; Algeorge G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):33-7. PubMed ID: 6264568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 9. [Presence of antibodies against rifampicin in patients under tuberculostatic treatment].
    Ion N; Jemma I; Sfetcu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):39-42. PubMed ID: 6264569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin.
    Wäre M; Heinivaara O; Elo R; Tala E
    Scand J Respir Dis Suppl; 1969; 69():59-63. PubMed ID: 4906375
    [No Abstract]   [Full Text] [Related]  

  • 11. [Side-effects of antitubercular chemoantibiotic therapy].
    Legramante A; Pelagalli LA; Santilli E
    Clin Ter; 1977 May; 81(4):363-79. PubMed ID: 195766
    [No Abstract]   [Full Text] [Related]  

  • 12. [Side effects in strictly supervised treatment with rifampicin and ethambutol].
    Năstase M; Năstase R; Brener E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):241-3. PubMed ID: 174182
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of rifampicin in tuberculous patients with liver diseases].
    Pozzi E; Menghini P
    G Ital Chemioter; 1972 Jul; 19(3):63-8. PubMed ID: 4671348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse effects of antibiotics.
    Cunha BA; Ristuccia AM
    Heart Lung; 1984 Sep; 13(5):465-72. PubMed ID: 6236175
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].
    Macquet V; Lafitte P; Rogeaux Y
    Lille Med; 1972 May; 17(5):755-61. PubMed ID: 5056293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surveillance and complications of antituberculosis chemotherapy].
    Duroux P
    Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe immunoallergic reaction in a patient treated for two months continuously with rifampicin].
    Fardet L; Lalande V; Meyohas MC; Frottier J; Meynard JL
    Presse Med; 1999 Nov; 28(37):2037-8. PubMed ID: 10605471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The optimal use of rifampicin in the polychemotherapy of pulmonary tuberculosis, with special reference to its liver-damaging potential: considerations and case studies].
    Salvati F; Mugnaini L; Altieri AM; De Marinis F
    Clin Ter; 1979 Jan; 88(1):45-50. PubMed ID: 436377
    [No Abstract]   [Full Text] [Related]  

  • 20. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.